In vitro transcription is a new technology that uses DNA templates to synthesize mRNA in vitro. Stemirna is one of the first companies in China to establish a full IVT mRNA platform. After continuous optimization of the platform, Stemirna is now able to synthesize mRNA of various lengths and functions, and has established a complete quality control system.

Sremirna established an artificial intelligence algorithm platform for mRNA to optimize the coding region and non-coding region of mRNA sequence, which greatly improved the protein expression level and expression duration of mRNA.

Stemirna has developed mRNAs of different lengths, structures and functions and applied them to research in the fields of anti-tumor, infectious disease prevention, rare disease treatment, gene editing, etc. By studying the application of different functional mRNAs in different therapeutic scenarios to exploit the maximum potential of mRNA applications.